United States - English - NLM (National Library of Medicine)

american health packaging - ribavirin (unii: 49717awg6k) (ribavirin - unii:49717awg6k) - ribavirin 200 mg - ribavirin capsules, usp in combination with interferon alfa-2b (nonpegylated) is indicated for the treatment of chronic hepatitis c (chc) in patients 3 years of age and older with compensated liver disease [see warnings and precautions ( 5.9, 5.10), and use in specific populations ( 8.4)]. the following points should be considered when initiating ribavirin capsules, usp combination therapy with intron a ® : - these indications are based on achieving undetectable hcv-rna after treatment for 24 or 48 weeks and maintaining a sustained virologic response (svr) 24 weeks after the last dose. - patients with the following characteristics are less likely to benefit from retreatment after failing a course of therapy: previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and genotype 1 infection [see clinical studies ( 14) ]. - no safety and efficacy data are available for treatment of longer than one year. ribavirin capsules combination therapy is contraindicated i

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

diomed developments ltd - salicylic acid; lactic acid - cutaneous gel - 120mg/1gram ; 40mg/1gram

United States - English - NLM (National Library of Medicine)

vizumax diagnostics llc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - barium sulfate 980 mg in 1 g - indicaciones y uso: para uso como agente de contraste en estudios radiográficos.these highlights do not include all the information needed to use, see full prescribing information for, initial u.s. approval

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - influenza split virus, inactivated -

United States - English - NLM (National Library of Medicine)

vizumax diagnostics llc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - ndications & usage: para uso como agente de contraste en estudios radiográficos.these highlights do not include all the information needed to use, see full prescribing information for, initial u.s. approval.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

denk pharma gmbh & co. kg - captopril - tablets - 25mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

denk pharma gmbh & co. kg - nifedipine - tablets prolonged-release - 20mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

denk pharma gmbh & co. kg - nifedipine - tablets prolonged-release - 10mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mycophenolate mofetil, quantity: 250 mg - capsule - excipient ingredients: croscarmellose sodium; magnesium stearate; indigo carmine; purified water; titanium dioxide; gelatin; iron oxide red; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - mycophenolate mofetil is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,mycophenolate mofetil is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.